At MDS World Awareness Day today - 25 October 2021 - we would like to point out how HARMONY Experts aim to improve the lives of people with blood cancer. Guillermo Sanz Read about our #MDS Big Data Research Project: bit.ly/3iQBiBq #BIGDATAFORBLOODCANCER #MDSWAD2021

Nuevos marcadores de progresión de la enfermedad en mielofibrosis mdpi.com/2072-6694/13/2…

#MPNHZ21 MEET OUR SPEAKERS Day 1 MPN Horizons 2021 Virtual Conference

Chess is like medicine, it isnt about destruction of your opponents but to understand them & yourself to fight the best fight. That's what I learnt from GothamChess & colleagues. One of my opponents is myelofibrosis, we can cure it! Play against me #ash21, bring my board. #mpnsm

👀Check out this review 👇 #mpn #mpnsm

Very exciting data at MPN Advances Day by Morten Holström re. vaccination against CALR mutations, a future potential treatment for patients with #mpnsm Several types of immune therapy for MPN are investigated accross the world, looking forward for innovative strategies soon!

Medical Session #1 at #MPNHZ21 Ruben A. Mesa, MD is speaking about the Future of MPN New Drugs. mpnhz21.cme-congresses.com #MPN

Approximately how many patients won't have a driver mutation, and what do you do with those patients❓ SHORT📰🔛MPN➡️bit.ly/3hXeCPQ Aaron Gerds MD, MS #meded #medicaleducation #SoMe #CME #CPE #doctors #pharmacists #cancer #rarediseases #oncology #hematology #medtwitter #mpnsm

Ya tenemos muy cerca la segunda edición de las Reuniones de pacientes GEMFIN. Esta vez nos centramos en la zona de Aragón-Navarra. Te dejamos el programa científico y te animamos a participar registrándote en: webinar-pacientes-gemfin.mfar.online/registro/ @sehh_es @MpnspainE

#ASH21 📅 11-14 Diciembre. 📣 Un programa lleno de sesiones científicas y esperamos que tengamos novedades en las NMP 🙏🤞🤞. Ensayos clínicos, nuevos inhibidores, combos, etc. Estaremos muy pendientes.

MPN Horizons 2021: Videos and presentations are now available for your review and download. 🎥 Read more about #MPNHZ21 and watch all videos of all sessions on demand🔽 mpn-advocates.net/mpn-horizons-v… #MPN #Conference #PatientAdvocacy

Ruxolitinib en pacientes con #mielofibrosis era seguro y bien tolerado, con tasas favorables de #GvHD, en un estudio piloto de fase I inicial ashpublications.org/bloodadvances/…

Join the discussion on research discussion from #ASH21 ⁦ASH⁩ x.com/i/spaces/1kvJp…

Driving groundbreaking research. Improving lives. The MPN Research Foundation. mpnresearchfoundation.org/impact/?fbclid…

Seven technologies to watch in 2022 nature.com/articles/d4158…

curetoday.com/view/momelotin…

🆕🚀Expert Q&A🔛myelofibrosis 4⃣minute video➡️bit.ly/3XUdI9S #mpn #hematologyoncology #bloodcancer @CanadianMpn @MPNAdvocate MPN Ad&Ed Int'l Stephen Oh MPNAA Voices of MPN MPNAdvocatesNetwork MPN Voice Fernando Iñiguez MPN Research Foundation Hematologyoncology Blood Cancer Alliance Blood-Cancer.com Blood Cancer Uncensored

#ASH22 | Rosa Ayala Medicina Interna Hospital 12 de Octubre presents BETi BMS-986158 + RUX/FED is reported to have acceptable and manageable safety profiles. BMS-986158 + RUX produced early and deep spleen volume reduction. Enrollment ongoing for RP2D. #medicalcongress #MPN #MPNsm @ASH22

An antibody for myelofibrosis – “that’s a true discovery” - Leukaemia Foundation leukaemia.org.au/stories/an-ant…

onclive.com/view/what-is-t…